Stay updated on Nivolumab +/- Ipilimumab in NECs Clinical Trial

Sign up to get notified when there's something new on the Nivolumab +/- Ipilimumab in NECs Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab +/- Ipilimumab in NECs Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record now presents detailed information about the completed NIPINEC Phase 2 study, including its design, participant criteria, treatments, outcome measures, and French study locations. It also includes investigator, publication, and study-record details.
    Difference
    53%
    Check dated 2026-11-08T15:18:09.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.2 to v3.8.0 while the page continues to display a 403 Forbidden error.
    Difference
    0.3%
    Check dated 2026-11-01T16:17:54.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH website updates and notes that some content may use “Super Intelligence” instead of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-25T15:37:13.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T20:36:06.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T20:31:10.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The study record page now displays a 403 Forbidden error with the standard error page elements, including a Home link and a revision note, indicating the record is temporarily unavailable due to access restrictions.
    Difference
    19%
    Check dated 2026-09-20T20:55:06.000Z thumbnail image

Stay in the know with updates to Nivolumab +/- Ipilimumab in NECs Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab +/- Ipilimumab in NECs Clinical Trial page.